You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

369 Results
Regimen
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Intent: Palliative
Funding:
New Drug Funding Program
    Zolbetuximab - First-line Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Sep 2025
Regimen
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Intent: Palliative
Funding:
New Drug Funding Program
    Zolbetuximab - First-line Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Sep 2025
Drug
Other Name(s): Welireg®
Updated
Sep 2025
Drug
Other Name(s): Akeega™
Updated
Sep 2025
Drug
Other Name(s): Reblozyl®
Updated
Sep 2025
Drug
Other Name(s): Blincyto®
Updated
Sep 2025
Drug
Other Name(s): Camptosar®
Updated
Sep 2025
Drug
Other Name(s): Imbruvica®
Updated
Sep 2025
Drug
Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™
Updated
Sep 2025
Drug
Other Name(s): Neupogen®, Grastofil®, Nivestym®, Nypozi®, Filra™
Updated
Sep 2025
Drug
Other Name(s): Femara®
Updated
Sep 2025
Drug
Other Name(s): Tykerb®
Updated
Sep 2025

Pages